
Resources: Posters
Cell killing dynamics and heterogeneity in engineered T-cells measured in live CellCage enclosures
April 21, 2026
AACR | American Association for Cancer Research
Shawn Levy Ph.D., SVP Scientific Affairs
Keywords: T-cell cytotoxicity, Live-cell imaging, Immunotherapy, Functional heterogeneity

This poster details a longitudinal study of engineered T-cells within CellCage™ enclosures, linking real-time killing dynamics and functional heterogeneity to specific transcriptomic profiles. The analysis reveals distinct "super-killer" subsets and exhaustion patterns that remain invisible to traditional end-point analysis.
FAQ's
How does the R3200 platform measure T-cell killing dynamics?
The R3200 platform utilizes CellCage™ enclosures to enable the continuous, longitudinal monitoring of T-cell interactions within a stable microenvironment. By integrating live-cell imaging with transcriptomics, the system tracks the specific timing and intensity of cell-mediated killing events and correlates these behaviors with the gene expression of individual cells.
What is the significance of capturing functional heterogeneity in engineered T-cells?
Capturing functional heterogeneity allows for the identification of distinct cytotoxic subsets, such as "super-killers" versus exhausted populations. This approach provides a high-resolution view of population efficacy that traditional end-point assays often fail to detect.

